European Archives - Page 549 of 1195 - European Medical Journal

Type I Interferons in the Pathogenesis and Treatment of Sjögren's Syndrome: An Update

Interferons (IFN) are a class of cytokines that are produced in response to pathogenic stimuli.1 The IFN family was divided into three classes: Type I, Type II, and Type III…

Jeffrey Sparks

Interview: Jeffrey A. Sparks

I confess that serendipity was a main driver of my career path. In college, I was a physics major with an interest in humanities…

Metabolic Syndrome and its Outcomes in Rheumatoid Arthritis: A Review

Metabolic syndrome is a cluster of health conditions linked to increased cardiovascular disease. It is found worldwide in increasing…

Interview feature images Rheum 9.1

Interview: Lorinda Chung

My father is a physician and served as an inspiration for me and my three older sisters to go into medicine. Having attended…

Primary Renal Hydatid in Children

Isolated renal hydatid disease, caused by the larvae of the parasitic tapeworm Echinococcus granulosus is a rare phenomenon and accounts…

The Role of Molecular Pathology, Early Testing, and Informatics in the Multidisciplinary Team Approach in Cancer Care: Interviews with Two Key Opinion Leaders

This article discusses how molecular pathology fits alongside traditional anatomical pathology, and the role of molecular MDTs in the management of patients with cancer.

EMJ Oncology 10 [Supplement 9] 2022

This article spotlights interviews EMJ conducted with two leading specialists in multidisciplinary care of patients with cancer: Russell Petty, Ninewells Hospital and Medical School, University of Dundee and NHS Tayside, Scotland, UK, and Helmut Popper, Institute of Pathology, Medical University of Graz, Austria.

Key pharma trends from Cannes Lions

In this episode, Helena and Marc are joined by Claire Gillis, CEO, VMLY&R Health, to discuss the health and pharma highlights from the recent Cannes Lions.

Vaccines and sustainability focus for GSK

In its annual Palio meeting, GSK discusses the growing threat to human health from infectious disease with a group of experts in immunology, vaccinology and epidemiology.

Treatment Landscape and Emerging Therapies in Oesophageal Cancer: Interviews with Two Key Opinion Leaders

EMJ conducted interviews in February 2022 with two key opinion leaders (KOL), Zachary Wilmer Reichenbach, who works in the Department of…